Skip to main content

Table 6 Group names and vaccines received on Days 0, 21 and 42

From: A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine

Group names Vaccines received
  Dose 1 (Day 0) Dose 2 (Day 21) Dose 3 (Day 42)
Group A TIV+Placebo 15 μg 15 μg
Group B TIV+Placebo 3.75 μg/AS03 3.75 μg/AS03
Group C 15 μg+TIV 15 μg Placebo
Group D 3.75 μg/AS03+TIV 3.75 μg/AS03 Placebo
Group E 15 μg+Placebo 15 μg TIV
Group F 3.75 μg/AS03+Placebo 3.75 μg/AS03 TIV